Improvement of fatigue-related symptoms in patients with major depression treated with venlafaxine, SSRIs, or placebo

被引：0
|
作者：
Mallick, R
Zhang, H
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [41] Specific fatigue-related items in self-rating depression scales do not bias an association between depression and fatigue in patients with coronary artery disease
    Bunevicius, Adomas
    Brozaitiene, Julija
    Stankus, Albinas
    Bunevicius, Robertas
    GENERAL HOSPITAL PSYCHIATRY, 2011, 33 (05) : 527 - 529
  • [42] Efficacy of venlafaxine extended-release compared with placebo in major depressive disorder patients by severity of anxiety symptoms
    Lyndon, G.
    Prieto, R.
    Wajsbrot, D.
    Allgulander, C.
    Bandelow, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S807 - S808
  • [43] A placebo-controlled trial of venlafaxine XR in patients with recurrent unipolar major depression to assess recurrence prevention
    Keller, M.
    Yan, B.
    Dunner, D.
    Ferguson, J.
    Friedman, E.
    Gelenberg, A.
    Hirschfeld, R.
    Kocsis, J.
    Kornstein, S.
    Nemeroff, C.
    Ninan, P.
    Rothschild, A.
    Schatzberg, A.
    Shelton, R.
    Thase, M.
    Trivedi, M.
    Zajecka, J.
    Ahmed, S.
    Musgnung, J.
    Parker-Zavod, E.
    Pedersen, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S233
  • [44] The Effect of Fatigue-Related Education on Pediatric Oncology Patients' Fatigue and Quality of Life
    Kudubes, Asli Akdeniz
    Bektas, Murat
    Mutafoglu, Kamer
    JOURNAL OF CANCER EDUCATION, 2019, 34 (06) : 1130 - 1141
  • [45] The Effect of Shortening-induced Torque Depression on Fatigue-related Sex Differences
    Gabel, Haley V.
    Debenham, Mathew I. B.
    Power, Geoffrey A.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2020, 52 (04): : 835 - 843
  • [46] Achieving remission with venlafaxine and fluoxetine in major depression: Its relationship to anxiety symptoms
    Davidson, JRT
    Meoni, P
    Haudiquet, V
    Cantillon, M
    Hackett, D
    DEPRESSION AND ANXIETY, 2002, 16 (01) : 4 - 13
  • [47] Rates of complete remission of individual symptoms in depressed patients treated with venlafaxine, selective serotonin reuptake inhibitors, or placebo
    Entsuah, R
    Zhang, J
    Fawcett, J
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S100 - S100
  • [48] Improvement in general life functioning with venlafaxine versus fluoxetine in outpatients with major depression
    Kalin, N
    Nemeroff, C
    Wan, G
    Panish, J
    Cantillon, M
    EUROPEAN PSYCHIATRY, 2002, 17 : 194S - 194S
  • [49] DEPRESSIVE SYMPTOMS AS PREDICTORS OF THE SEVERITY OF FATIGUE IN MAJOR DEPRESSION
    Ferentinos, P.
    Kontaxakis, V.
    Havaki-Kontaxaki, B.
    Dikeos, D.
    Papadimitriou, G.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [50] A COMPARISON OF VENLAFAXINE, TRAZODONE, AND PLACEBO IN MAJOR DEPRESSION (VOL 14, PG 99, 1994)
    CUNNINGHAM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1994, 14 (04) : 292 - 292
12345